Eliem Therapeutics, Inc

Historical 13F Holders

Symbol
ELYM
CUSIP
28658R106
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 77 51.9 M $63.4 M
2024 Q4 81 55.7 M $100 M
2024 Q3 73 54.7 M $278 M
2024 Q2 50 49.9 M $355 M
2024 Q1 24 16.9 M $46.2 M
2023 Q4 26 16.9 M $45.5 M
2023 Q3 24 16.7 M $44.0 M
2023 Q2 23 16.7 M $46.8 M
2023 Q1 20 16.7 M $48.4 M
2022 Q4 22 16.6 M $61.1 M
2022 Q3 23 14.8 M $47.8 M
2022 Q2 30 15.1 M $45.7 M
2022 Q1 44 17.5 M $147 M
2021 Q4 36 17.4 M $182 M
2021 Q3 33 17.3 M $311 M